Holen Sie sich die Stockscreener-App
211.96
2.79%
-6.08
Vorhandelsmarkt:
208.77
-3.19
-1.51%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ABBV?
Forum
Prognose
Dividendenhistorie
Abbvie Inc Aktie (ABBV) Neueste Nachrichten
Colorado Judge Denies AbbVie's Bid To Block State Drug Law - Law360
Citigroup Lowers Price Target for AbbVie (ABBV) to $235 Amidst N - GuruFocus
AbbVie, Novartis Win Block of Oklahoma Drug Discount Law - Bloomberg Law News
The AbbVie Decision and the Economics of Corporate Control Markets - The National Law Review
Do Wall Street Analysts Like AbbVie Stock? - Barchart.com
JP Morgan Raises Price Target on AbbVie (ABBV) to $260, Maintains Overweight Rating | ABBV Stock News - GuruFocus
ABBV Q3 Deep Dive: Immunology Growth and Pipeline Expansion Offset Margin Pressure - TradingView
Here’s What Drove Baron Health Care Fund to Add AbbVie (ABBV) to Its Portfolio - Insider Monkey
Goldman Sachs Adjusts Price Target on AbbVie to $223 From $218 - MarketScreener
Analyst on AbbVie (ABBV): ‘Stay Long’ - Insider Monkey
Obermeyer Wealth Partners Sells 12,006 Shares of AbbVie Inc. $ABBV - MarketBeat
Bank of New York Mellon Corp Cuts Position in AbbVie Inc. $ABBV - MarketBeat
Street View: Immunology strength holds at AbbVie despite aesthetics drag - TradingView
My Favorite Dividend King to Buy in November - The Motley Fool
AbbVie Inc. $ABBV Shares Acquired by Machina Capital S.A.S. - MarketBeat
AbbVie Inc. $ABBV Holdings Lifted by Tsfg LLC - MarketBeat
AbbVie Inc. $ABBV Shares Sold by Bank of Montreal Can - MarketBeat
Raymond James raises Abbvie stock price target to $256 on solid growth - Investing.com Nigeria
AbbVie Inc. $ABBV Shares Sold by Texas Bank & Trust Co - MarketBeat
Torray Investment Partners LLC Increases Stock Position in AbbVie Inc. $ABBV - MarketBeat
Raymond James Adjusts Price Target on AbbVie to $256 From $250, Maintains Outperform Rating - MarketScreener
JPMorgan Adjusts Price Target on AbbVie to $260 From $250, Maintains Overweight Rating - MarketScreener
BNP Paribas Exane Adjusts Price Target on AbbVie to $203 From $197, Maintains Neutral Rating - MarketScreener
Burney Co. Has $11.59 Million Stock Position in AbbVie Inc. $ABBV - MarketBeat
Is AbbVie Inc. stock undervalued at current priceGap Up & High Accuracy Investment Entry Signals - newser.com
Sigma Planning Corp Sells 4,396 Shares of AbbVie Inc. $ABBV - MarketBeat
United States Multiple Myeloma Market Research Report 2025-2033, Profiles of Key PlayersNovartis, Abbvie, Sanofi, Johnson and Johnson, Baxter, Pfizer, Takeda, and Bristol-Myers Squibb - GlobeNewswire
Targeted Drug Delivery Market Set to Witness Massive Growth - openPR.com
Will AbbVie Inc. stock attract more institutional investorsJuly 2025 Price Swings & Verified Momentum Stock Alerts - newser.com
Will AbbVie Inc. stock beat EPS estimatesProduct Launch & Real-Time Stock Movement Alerts - newser.com
Why AbbVie Inc. (4AB) stock stays on top picks2025 Volume Leaders & Expert Curated Trade Ideas - newser.com
How to recover losses in AbbVie Inc. stockWeekly Profit Analysis & Stock Portfolio Risk Management - newser.com
Is AbbVie Inc. (4AB) stock undervalued after correctionWeekly Stock Summary & Capital Efficient Trading Techniques - newser.com
Reversal indicators forming on AbbVie Inc. stockEarnings Trend Report & Real-Time Buy Signal Alerts - newser.com
Can AbbVie Inc. stock retain market dominance2025 Valuation Update & Reliable Volume Spike Trade Alerts - newser.com
State of Michigan Retirement System Buys 1,400 Shares of AbbVie Inc. $ABBV - MarketBeat
Nicholas Company Inc. Cuts Holdings in AbbVie Inc. $ABBV - MarketBeat
Tredje AP fonden Cuts Position in AbbVie Inc. $ABBV - MarketBeat
Triglav Investments D.O.O. Lowers Stake in AbbVie Inc. $ABBV - MarketBeat
SS&H Financial Advisors Inc. Buys 8,330 Shares of AbbVie Inc. $ABBV - MarketBeat
TIAA Trust National Association Sells 10,325 Shares of AbbVie Inc. $ABBV - MarketBeat
Accuvest Global Advisors Sells 1,690 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Purchased by Great Lakes Retirement Inc. - MarketBeat
Why AbbVie Stock Flopped on Friday - AOL.com
AbbVie (ABBV) Surpasses Q3 Expectations with Strong Revenue Grow - GuruFocus
Earnings Scorecard: 24 out of 25 healthcare firms deliver EPS wins this week - Seeking Alpha
ABBV Stock: $250 May Be the New Floor After Big Q3 Earnings Beat - MSN
AbbVie (ABBV) Reports $14.5 Billion One-Off Loss, Undercutting Bullish Margin Recovery Narratives - Sahm
Longbow Finance SA Purchases 37,626 Shares of AbbVie Inc. $ABBV - MarketBeat
Lifeworks Advisors LLC Purchases 1,575 Shares of AbbVie Inc. $ABBV - MarketBeat
Crescent Sterling Ltd. Has $2.90 Million Stake in AbbVie Inc. $ABBV - MarketBeat
Center for Financial Planning Inc. Boosts Stake in AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Bought by Syverson Strege & Co - MarketBeat
Leeward Financial Partners LLC Buys New Stake in AbbVie Inc. $ABBV - MarketBeat
Haven Private LLC Takes Position in AbbVie Inc. $ABBV - MarketBeat
Tax Court allows ordinary deduction of termination fees - Journal of Accountancy
Assetmark Inc. Decreases Position in AbbVie Inc. $ABBV - MarketBeat
Will AbbVie Inc. (Common Stock) (4AB0) stock test record highs in 2025Long Setup & Low Risk High Win Rate Picks - newser.com
AbbVie Inc. (NYSE:ABBV) to Issue Quarterly Dividend of $1.73 - MarketBeat
AbbVie (ABBV) Margin Compression Reinforces Investor Caution After $14.5 Billion One-Off Loss - Yahoo Finance
AbbVie (NYSE:ABBV) Updates Q4 2025 Earnings Guidance - MarketBeat
AbbVie Inc. stock underperforms Friday when compared to competitors - MSN
AbbVie (NYSE:ABBV) Stock Price Down 4.4%Should You Sell? - MarketBeat
Five Things To Know About AbbVie’s Q3 Sales And Earnings Report - Citeline News & Insights
Looking Into AbbVie Inc's Recent Short Interest - Fidelity
1.38%
0.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):